BIO Double Helix Sponsor
Sponsors

Company Profile

Primorigen, LLC

Metabolic
Gene/Cell Therapy
Microarrays

510 Charmany Drive
Madison, WI 53719
USA
www.primorigen.com 		Incorporated in 2005
10 Employees 		Privately Held

This Year's Highlights

  • In advanced development of unique, well-characterized match pair antibodies and mulitplexed fluorescence immunoassay antibody microarrays for protein detection, quantitation.
  • Raised $2.525 M. in recent funding from institution, vc and angel sources
  • Expanded facilities and capabilities to include contract services in a) multiplexed immunoassays for quantitative protein detection, c) rapid antibody development, d) protein expression, purification, e) statistical design of experiment optimization.

Anticipated Highlights

  • First family of microarray products for diabetes to be launched in Q1 '08.
  • First family of microarray products for regenerative medicine applications in development as planned second product launch.
  • Co-development alliances under discussion for development of content-based microarrays for other applications.

Corporate Mission

Primorigen develops, manufactures, and distributes laboratory products for cell characterization, quantitative protein detection, and basic biochemical research. These products include thin-film nitrocellulose slides and kits, well-characterized monoclonal antibodies, target protein standards, and other laboratory reagents. The company is developing new multiplexed immunoarray products for several applications. Primorigen also offers contract services for product development and manufacturing of proteins, monoclonal antibodies, quantitative assays, and complete microarrays.